Verition Fund Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KNSA
BBA
Verition Fund Management's KNSA Position: Q3 2026 in Review
Verition Fund Management sold out of Kiniksa Pharmaceuticals (KNSA) in Q3 2026, closing a stake of 7,500 shares — an estimated $480K sold.
Verition Fund Management first reported a position in KNSA in Q1 2020 and held it in 6 quarters. The position peaked at $1.08M in Q4 2024. 300 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.
- Verition Fund Management reported no remaining Kiniksa Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Verition Fund Management sold 7,500 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $480K.
- Verition Fund Management first reported a position in Kiniksa Pharmaceuticals in Q1 2020 and held it in 6 quarters.
- Verition Fund Management's Kiniksa Pharmaceuticals position peaked at $1.08M in Q4 2024.
- 300 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.
Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.